Shionogi & Co., Ltd. - Company Profile and SWOT Analysis
Summary
Shionogi & Co., Ltd. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Shionogi & Co., Ltd. (Shionogi or 'the group') produces and sells pharmaceutical products. The company is involved in the research, development, manufacture, and marketing of ethical drugs, over the counter (OTC) drugs and diagnostic products. It caters to the healthcare needs and addresses the social issues of society. The company offers its products under various brands such as AIMIX, IRTRA, Crestor, Irbetan, Cymbalta, Pirespa, Differin, Rapiacta, Finibax, OxyContin, OxiNorm, OxiFast, Sedes, Correct Series, opon Series and Brightpoc Flu. Shionogi has 51 subsidiaries and three affiliates. It operates in Japan, Europe, North America and other regions of the world. The company is headquartered in Osaka, Japan.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook